The author also reports that the SNRI venlafaxine, is also effective and relatively cheap but its unpleasant withdrawal syndrome is a drawback. Pregabalin was the only compound whose overall acceptability was superior to placebo. Concerns about misuse, however, may limit its appeal, particularly now it has been classified as a Schedule 3 controlled drug.